Andrea has focused on partnering early stage life sciences technologies for over 15 years. Since 2008 she has been at Cancer Research UK - Boston, building relationships between Cancer Research UK and the biotech/pharma industry throughout the US. Prior to CRUK, Andrea was at MIT's Technology Licensing Office, where she engaged with both established and startup companies to license technology from MIT, the Whitehead Institute and Lincoln Laboratory. Previous to that, Andrea was one of the early employees at Variagenics, a personalized medicine startup out of MIT. Initially hired as a scientist, after three years Andrea transitioned into business development, where she spent a further three years focused on alliance development in the US and Europe, until the company was acquired. Andrea received her undergraduate degree in Biology at MIT and her PhD from Harvard, followed by a postdoctoral fellowship in Genetics Institute's Small Molecule Drug Discovery group.